The abstract is read at the publisher; the summary is JClub's.
HSD17B13, GPAT4, and LiveDrop diffuse similarly in the ER and on lipid droplets, then become nano-confined at the LD surface, enabling selective accumulation.
- Why it matters: Mislocalization of LD-targeted ER proteins such as HSD17B13 and PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease, yet how ER proteins traffic and accumulate on LDs is unclear.
- What they did: Using minimal fluorescence photon fluxes nanoscopy and highly inclined and laminated optical single-molecule tracking with machine learning, the study tested LiveDrop targeting by mutating residues in its targeting motif.
- The result: LiveDrop confinement and LD accumulation depend on motif residues that mediate preferential interactions with nanoscale membrane domains, and trajectories show bidirectional trafficking across seipin-containing ER-LD bridges.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.